# Simethicone as Part of ERAS in Bariatric Surgery Patients

> **NCT06812832** · PHASE4 · RECRUITING · sponsor: **Madigan Army Medical Center** · enrollment: 260 (estimated)

## Conditions studied

- Simethicone
- Bariatric Surgery
- Post-operative Pain

## Interventions

- **DRUG:** Simethicone 80 MG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06812832
- **Lead sponsor:** Madigan Army Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-08
- **Primary completion:** 2028-03
- **Final completion:** 2029-03
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2025-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06812832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06812832, "Simethicone as Part of ERAS in Bariatric Surgery Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06812832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*